An Aggregation‐Induced Polymerization Poly(Disulfide)‐Drug Nanoplatform for Autoimmune Uveitis Therapy via Inhibiting the cGAS‐STING Pathway
Advanced Science · 2026
DOI: 10.1002/advs.76813 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yuelan Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Medical Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory For the Prevention and Treatmen…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Uveitis, Nucleotidyltransferases, Dexamethasone. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation Key Program, National Natural Science Foundation of China, Chongqing Science and Technology Bureau Mountaineering Project.
Abstract (Originalsprache)
Autoimmune uveitis is a sight‐threatening inflammatory disease in which the cGAS‐STING signaling pathway exacerbates inflammation by recognizing excessive cell‐free DNA (cfDNA). However, conventional cfDNA scavengers have limited blood‐retinal barrier penetration, and monotherapies cannot control the complex inflammatory network. Herein, we developed a cationic poly(disulfide)‐drug nanoplatform (LA/DexP), which self‐assembled via salt bridge interactions and aggregation‐induced polymerization between a guanidyl‐functionalized lipoic acid derivative (LA) and dexamethasone phosphate (DexP). This platform is designed to synergistically inhibit the cGAS‐STING pathway and achieve efficient intraocular drug delivery. LA/DexP functioned as an efficient scavenger of cfDNA through electrostatic interaction, thereby inhibiting cGAS‐STING overactivation. Meanwhile, it leveraged thiol‐disulfide exchange to enhance blood‐retinal barrier penetration, achieving a 5.09‐fold higher apparent permeability coefficient than free DexP, and exhibited ROS‐responsive drug release. In an experimental autoimmune uveitis mouse model, LA/DexP treatment significantly reduced cfDNA levels and inhibited cGAS‐STING signaling. It also downregulated pro‐inflammatory cytokine expression, promoted macrophage polarization from the pro‐inflammatory M1 to the anti‐inflammatory M2 phenotype, and rebalanced Th1/Th17‐Treg cell subsets. These combined effects effectively inhibited uveitis severity. In summary, this study establishes a highly barrier‐permeable nanoplatform that synergistically integrates drug delivery with cGAS‐STING pathway inhibition, offering a promising therapeutic strategy for autoimmune uveitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmology Medical Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory For the Prevention and Treatment of Major Blinding Eye Diseases, Chongqing Branch (Municipality Divis…
- Department of Ophthalmology, Joint Research Laboratory For Ocular Immunology and Retinal Injury Repair, The First Affiliated Hospital of Zhengzhou University, Henan International, Henan Province Eye Hospital, Zhengzhou,…
ORCID-Profile: Peizeng Yang
Förderung
- National Natural Science Foundation Key Program
- National Natural Science Foundation of China
- Chongqing Science and Technology Bureau Mountaineering Project
- Science and Technology Cooperation Project of the First Affiliated Hospital of Zhengzhou University
- China Postdoctoral Science Foundation
- Postdoctoral Fellowship Program of the China Postdoctoral Science Foundation
- Chongqing Medical Youth Top-notch Talent Project
Zitieren
APA
Wu, Y., Geng, W., Dai, Q., Zhang, W., Lai, Y., Zhang, P., Zhou, C., Wang, Y., Cao, Q., Luo, X., Lai, Y., Huang, C., & Yang, P. (2026). An Aggregation‐Induced Polymerization Poly(Disulfide)‐Drug Nanoplatform for Autoimmune Uveitis Therapy via Inhibiting the cGAS‐STING Pathway. Advanced Science. https://doi.org/10.1002/advs.76813
Vancouver
Wu Y, Geng W, Dai Q, Zhang W, Lai Y, Zhang P, et al. An Aggregation‐Induced Polymerization Poly(Disulfide)‐Drug Nanoplatform for Autoimmune Uveitis Therapy via Inhibiting the cGAS‐STING Pathway. Advanced Science. 2026. doi:10.1002/advs.76813
BibTeX
@article{Wu2026,
author = {Wu, Yuelan and Geng, Wenbo and Dai, Qinjin and Zhang, Wanyun and Lai, Yuxian and Zhang, Pei and Zhou, Chunjiang and Wang, Yinuo and Cao, Qingfeng and Luo, Xiang and Lai, Yujie and Huang, Changwei and Yang, Peizeng},
title = {An Aggregation‐Induced Polymerization Poly(Disulfide)‐Drug Nanoplatform for Autoimmune Uveitis Therapy via Inhibiting the cGAS‐STING Pathway},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76813}
}
EUVIMED